TrianglePUBLICATIONS · 23394705
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Hematol Oncol
- Publication date
- 2013 Feb 8
- First author
- Liu H
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Liu H
- type
- Author
- name
- Zhai X
- type
- Author
- name
- Song Z
- type
- Author
- name
- Sun J
- type
- Author
- name
- Xiao Y
- type
- Author
- name
- Nie D
- type
- Author
- name
- Zhang Y
- type
- Author
- name
- Huang F
- type
- Author
- name
- Zhou H
- type
- Author
- name
- Fan Z
- type
- Author
- name
- Tu S
- type
- Author
- name
- Li Y
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Liu H
- type
- Author
- name
- Zhai X
- type
- Author
- name
- Song Z
- type
- Author
- name
- Sun J
- type
- Author
- name
- Xiao Y
- type
- Author
- name
- Nie D
- type
- Author
- name
- Zhang Y
- type
- Author
- name
- Huang F
- type
- Author
- name
- Zhou H
- type
- Author
- name
- Fan Z
- type
- Author
- name
- Tu S
- type
- Author
- name
- Li Y
- type
- Author
- bibliography ids
- nci-bib-d3f2098f2df253287b816db3
- book metadata
- content sha256
- 525347f1b9de8006f264f8abf0c5b36627760718143d89d10300452481fc11cd
- document type
- citation
- dois
- 10.1186/1756-8722-6-15
- electronic publication date
- display
- 2013 Feb 8
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23394705
- immutable id
- pubmed:23394705@525347f1b9de8006f264f8abf0c5b36627760718143d89d10300452481fc11cd
- journal
- abbreviation
- J Hematol Oncol
- issn electronic
- 1756-8722
- issn print
- Source null
- issue
- Source null
- name
- Journal of hematology & oncology
- nlm unique id
- 101468937
- pages
- 15
- volume
- 6
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 23394705
- provenance
- batch id
- 99e008dabc339d38fd44
- provider
- NCBI PubMed ESummary
- record sha256
- dbd707d58026fdaae7004680a700ab7cf2a58d18b75614b107a0ce4e1f13f328
- response sha256
- 804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
- retrieved at
- 2026-09-09T23:46:55.094762+00:00
- publication date
- display
- 2013 Feb 8
- precision
- day
- year
- 2013
- publication types
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study.
Preserved source evidence · Not medical advice